A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures
- Conditions
- Subjects Who Have Undergone Benign Non-tumor TORS Procedures Using the da Vinci Surgical System
- Interventions
- Device: robotic surgery using the da Vinci Surgical System
- Registration Number
- NCT02002845
- Lead Sponsor
- Intuitive Surgical
- Brief Summary
A retrospective multicenter investigation of the use of the da Vinci® Surgical System in Non-Tumor Based TORS Procedures. The study objectives are to evaluate the safety and effectiveness of the da Vinci Surgical System in subjects undergoing Benign Non-tumor procedures.
- Detailed Description
Primary Effectiveness Endpoint:
• Ability to complete procedure without a need for conversion to a non-robotic approach
Safety Endpoint:
Assessment of adverse events through post-operative follow-up including but not limited to:
• Bleeding
▪ Mortality
Additional endpoints evaluated may include:
* Procedure times
* Length of hospital stay
* Volume of tissue resected
* Use of tissue sealants
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 285
- The specific surgical procedure involved a lingual tonsillectomy, tongue base resection, or a partial glossectomy procedure.
- Subject was ≥18 years of age at the time of procedure
- Subject underwent a benign non-tumor TORS procedure that did not involve either a lingual tonsillectomy, tongue base resection or partial glossectomy.
- Subject underwent a TORS procedure for oropharyngeal cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Robotic arm robotic surgery using the da Vinci Surgical System Patient who have undergone benign non-tumor TORS procedures using the da Vinci Surgical System
- Primary Outcome Measures
Name Time Method Primary Effectiveness Endpoint intra-operative Ability to complete procedure without a need for conversion to a non-robotic approach
Primary Safety endpoint up to 30 days after surgery Assessment of adverse events through post-operative follow-up including but not limited to:
• Bleeding
▪ Mortality
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States
Middlesex Hospital
🇺🇸Middletown, Connecticut, United States
St. Jose Mercey Health System
🇺🇸Ypsilanti, Michigan, United States